{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:16:18Z","timestamp":1787793378655,"version":"build-2784847793"},"reference-count":42,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":287,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1530\/eor-2024-0133","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:41:46Z","timestamp":1746513706000},"page":"258-266","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":4,"title":["Effects of discontinuing different antiresorptive regimens on medication-related osteonecrosis of the jaw in patients undergoing dental procedures: a systematic review and network meta-analysis"],"prefix":"10.1530","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-2138","authenticated-orcid":true,"given":"Kasidid","family":"Ruksakiet","sequence":"first","affiliation":[{"name":"Department of Restorative Dentistry, Faculty of Dentistry, Naresuan University 1 , ,","place":["Phitsanulok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-8195","authenticated-orcid":true,"given":"Atthakorn","family":"Jarusriwanna","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Faculty of Medicine, Naresuan University 2 , ,","place":["Phitsanulok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1052-3051","authenticated-orcid":true,"given":"Wuttapon","family":"Sadaeng","sequence":"additional","affiliation":[{"name":"Department of Oral Diagnosis, Faculty of Dentistry, Naresuan University 3 , ,","place":["Phitsanulok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5827-6411","authenticated-orcid":true,"given":"Artit","family":"Laoruengthana","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Faculty of Medicine, Naresuan University 2 , ,","place":["Phitsanulok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-1327","authenticated-orcid":true,"given":"Thanyaporn","family":"Sang-Ngoen","sequence":"additional","affiliation":[{"name":"Department of Oral Biology, Faculty of Dentistry, Naresuan University 4 , ,","place":["Phitsanulok, Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6222-6476","authenticated-orcid":true,"given":"Teerapon","family":"Dhippayom","sequence":"additional","affiliation":[{"name":"The Research Unit of Evidence Synthesis (TRUES), Faculty of Pharmaceutical Sciences, Naresuan University 5 , ,","place":["Phitsanulok, Thailand"]},{"name":"Department of Pharmacotherapy, University of Utah College of Pharmacy 6 , , ,","place":["Salt Lake City, Utah, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"2026070711165581000_bib1","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EJE-18-0056","article-title":"Therapy of endocrine disease: denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis","volume":"179","author":"Anastasilakis","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2026070711165581000_bib2","first-page":"1029","article-title":"Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Menshawy","year":"2018","journal-title":"Support Care Cancer"},{"key":"2026070711165581000_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"key":"2026070711165581000_bib4","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society guideline update","volume":"105","author":"Shoback","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070711165581000_bib5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO clinical practice guidelines","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"key":"2026070711165581000_bib6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"2026070711165581000_bib7","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"2026070711165581000_bib8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral efficacy with risedronate therapy (VERT) study group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"2026070711165581000_bib9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2026070711165581000_bib10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"2026070711165581000_bib11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"2026070711165581000_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100416","article-title":"Experience with denosumab (XGEVA\u00ae) for prevention of skeletal-related events in the 10 years after approval","volume":"33","author":"Cadieux","year":"2022","journal-title":"J Bone Oncol"},{"key":"2026070711165581000_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002014","article-title":"Bisphosphonates in the treatment of patients with metastatic breast, lung, and prostate cancer: a meta-analysis","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine"},{"key":"2026070711165581000_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40273-017-0595-0","article-title":"Cost-effectiveness of treatments for the management of bone metastases: a systematic literature review","volume":"36","author":"Andronis","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"2026070711165581000_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40273-020-00965-9","article-title":"An updated systematic review of cost-effectiveness analyses of drugs for osteoporosis","volume":"39","author":"Li","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"2026070711165581000_bib16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.adaj.2021.05.016","article-title":"What is MRONJ?","volume":"152","author":"Mark","year":"2021","journal-title":"J Am Dent Assoc"},{"key":"2026070711165581000_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2026070711165581000_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2026070711165581000_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cre2.698","article-title":"Incidence and risk factors for medication-related osteonecrosis after tooth extraction in cancer patients-a systematic review","volume":"9","author":"Schwech","year":"2023","journal-title":"Clin Exp Dent Res"},{"key":"2026070711165581000_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jcm10010152","article-title":"Denosumab discontinuation and the rebound phenomenon: a narrative review","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J Clin Med"},{"key":"2026070711165581000_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100423","article-title":"Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: a real-world machine learning approach","volume":"34","author":"Jacobson","year":"2022","journal-title":"J Bone Oncol"},{"key":"2026070711165581000_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MLR.0000000000001294","article-title":"Duration of bisphosphonate drug holidays and associated fracture risk","volume":"58","author":"Curtis","year":"2020","journal-title":"Med Care"},{"key":"2026070711165581000_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/jcm12010239","article-title":"Management of tooth extraction in patients taking antiresorptive drugs: an evidence mapping review and meta-analysis","volume":"12","author":"Liu","year":"2022","journal-title":"J Clin Med"},{"key":"2026070711165581000_bib24","article-title":"The effect of antiresorptive drug holidays on medication-related osteonecrosis of the jaw: a systematic review and meta-analysis","volume":"14","author":"Aboalela","year":"2022","journal-title":"Cureus"},{"key":"2026070711165581000_bib25","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026070711165581000_bib26","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026070711165581000_bib27","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026070711165581000_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcms.2015.02.018","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction","volume":"43","author":"Bodem","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"2026070711165581000_bib29","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00198-021-05995-3","article-title":"Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study","volume":"32","author":"Hasegawa","year":"2021","journal-title":"Osteoporos Int"},{"key":"2026070711165581000_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5125\/jkaoms.2023.49.2.68","article-title":"The effect of drug holiday before tooth extraction on the development of medication-related osteonecrosis of the jaw in cancer patients receiving intravenous bisphosphonates","volume":"49","author":"Karaca","year":"2023","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"2026070711165581000_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5125\/jkaoms.2020.46.1.78","article-title":"The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction","volume":"46","author":"Kang","year":"2020","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"2026070711165581000_bib32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jormas.2022.03.020","article-title":"Incidence and risk factors associated to medication-related osteo necrosis of the jaw (MRONJ) in patients with osteoporosis after tooth extractions. a 12-months observational cohort study","volume":"123","author":"Cuozzo","year":"2022","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"2026070711165581000_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.oooo.2021.06.003","article-title":"Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation","volume":"133","author":"Ottesen","year":"2022","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2026070711165581000_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J Clin Densitom"},{"key":"2026070711165581000_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study","volume":"126","author":"Hallmer","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2026070711165581000_bib36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bone.2005.07.023","article-title":"Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy","volume":"38","author":"Leu","year":"2006","journal-title":"Bone"},{"key":"2026070711165581000_bib37","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.3390\/jcm10132988","article-title":"Comparison of the effect of oral versus intravenous bisphosphonate administration on osteoclastogenesis in advanced-stage medication-related osteonecrosis of the jaw patients","volume":"10","author":"Kim","year":"2021","journal-title":"J Clin Med"},{"key":"2026070711165581000_bib38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ajoms.2017.07.008","article-title":"Discontinuing oral bisphosphonate therapy during dental extraction does not prevent osteonecrosis of the jaw: a multicenter retrospective study of 341 patients with propensity score matching analysis","volume":"29","author":"Kawakita","year":"2017","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"2026070711165581000_bib39","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","article-title":"A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?","volume":"28","author":"Hasegawa","year":"2017","journal-title":"Osteoporos Int"},{"key":"2026070711165581000_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00198-018-4746-8","article-title":"Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study","volume":"30","author":"Hasegawa","year":"2019","journal-title":"Osteoporos Int"},{"key":"2026070711165581000_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96480-8","article-title":"Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients","volume":"11","author":"Soutome","year":"2021","journal-title":"Sci Rep"},{"key":"2026070711165581000_bib42","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.3390\/ijerph19084624","article-title":"Relationship between drug holidays of antiresorptive agents and surgical outcomes in cancer patients with medication-related osteonecrosis of the jaw","volume":"19","author":"Otsuru","year":"2022","journal-title":"Int J Environ Res Public Health"}],"container-title":["EFORT Open Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eor.bioscientifica.com\/view\/journals\/eor\/10\/5\/EOR-2024-0133.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eor.bioscientifica.com\/downloadpdf\/journals\/eor\/10\/5\/EOR-2024-0133.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article-pdf\/10\/5\/258\/14328\/eor-2024-0133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article-pdf\/10\/5\/258\/14328\/eor-2024-0133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:52:54Z","timestamp":1783439574000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article\/10\/5\/258\/1887\/Effects-of-discontinuing-different-antiresorptive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,5]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eor-2024-0133","relation":{},"ISSN":["2058-5241"],"issn-type":[{"value":"2058-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}